Search

everythinglearnresearchcommunity

for

Search:↓

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

Sebaceous glands are often preserved and PPARy expression is constant in some cases of Central Centrifugal Cicatricial Alopecia.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

CCCA may be caused by both hair traction and an immune response.

Low-dose metformin may help hair regrowth and reduce inflammation in CCCA.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

Black women with CCCA are more likely to have uterine fibroids.

Topical metformin 10% cream may help treat central centrifugal cicatricial alopecia.

Using minoxidil for hair loss might rarely cause a vision problem where fluid builds up under the retina.

Oral Minoxidil can cause serious eye problems, but stopping it can improve vision.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.

Wearing a high-quality wig improved a woman's mood and life quality, and the authors suggest insurance should cover the cost of wigs.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

More research is needed on CCCA in children, especially Black and Asian adolescents.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Minoxidil may cause vision problems.

The authors maintain there is a significant link between vitamin D deficiency and central centrifugal cicatricial alopecia in Black patients, and call for more research on the topic.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Accurate diagnosis is crucial for effective treatment of hair loss.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.